Celltrion not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
4 in Phase 3
1 in Phase 1
Drugs
5
in active trials · 40 in all
Trials
6 active
57 since 2021
Drugs5
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 3 | Feb 2027Phase 3 trial completes | |||
| Next date | Feb 2027 · Phase 3 trial completes | ||||
| Also tested for | Non Squamous Non Small Cell Lung Cancer | ||||
| Open drug page | |||||
— |
Phase 3 | Feb 2027Phase 3 trial completes | |||
| Next date | Feb 2027 · Phase 3 trial completes | ||||
| Also tested for | Relapsing-remitting Multiple Sclerosis | ||||
| Open drug page | |||||
— |
Phase 3 | 8 Mar 2027Phase 3 trial completes | |||
| Next date | 8 Mar 2027 · Phase 3 trial completes | ||||
| Also tested for | Refractory or Relapsed Multiple Myeloma | ||||
| Open drug page | |||||
— |
Phase 3 | — | |||
| Also tested for | Plaque Psoriasis | ||||
| Open drug page | |||||
CT-P52not checked |
— |
Phase 1 | — | ||
| Open drug page | |||||
About
- No active trial
- 35 other drugs
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 16 Nov 2026 Industry-sponsored drug trials since 2021